EDGAR Filing Documents for 0001669191-21-000955

Form C/A - Offering Statement: [Amend]

SEC Accession No. 0001669191-21-000955

Filing Date

2021-09-24

Accepted

2021-09-24 13:15:03

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	C/A
1		primary_doc.xml	C/A	10204
2	OFFERING STATEMENT PDF	offeringstatement.pdf	EX-99	102178
3	OFFERING PAGE JPG	offeringpage.jpg	GRAPHIC	1477164
4	CPA REVIEW REPORT	reviewletter.pdf	EX-99	583504
5	CERTIFICATE OF INCORPORATION	certificateofincorporation.pdf	EX-99	1419459
6	CORPORATE BYLAWS	corporatebylaws.pdf	EX-99	243726
7	ADDITIONAL INFORMATION	otherfinancial.pdf	EX-99	157305
8	IMAGE ATTACHMENTS HTML	imageattachments.htm	EX-99	244
	Complete submission text file	0001669191-21-000955.txt		5488448

Mailing Address 2145 S CLERMONT ST SUITE 3 DENVER CO 80222

Business Address 2145 S CLERMONT ST STE 3 DENVER CO 80222 5106982462

Canine Life Sciences Inc. (Filer) CIK: 0001857342 (see all company filings)

IRS No.: 844068759 | State of Incorp.: CO
Type: C/A | Act: 33 | File No.: 020-28727 | Film No.: 211276433